BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33301029)

  • 1. MYC-induced human acute myeloid leukemia requires a continuing IL-3/GM-CSF costimulus.
    Bulaeva E; Pellacani D; Nakamichi N; Hammond CA; Beer PA; Lorzadeh A; Moksa M; Carles A; Bilenky M; Lefort S; Shu J; Wilhelm BT; Weng AP; Hirst M; Eaves CJ
    Blood; 2020 Dec; 136(24):2764-2773. PubMed ID: 33301029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
    Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
    Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor regulates the expression of granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors on human acute myeloid leukemia cells.
    Elbaz O; Budel LM; Hoogerbrugge H; Touw IP; Delwel R; Mahmoud LA; Löwenberg B
    Blood; 1991 Mar; 77(5):989-95. PubMed ID: 1825289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor eliminates acute myeloid leukemia cells with the potential to initiate leukemia in immunodeficient mice, but spares normal hemopoietic stem cells.
    Terpstra W; Rozemuller H; Breems DA; Rombouts EJ; Prins A; FitzGerald DJ; Kreitman RJ; Wielenga JJ; Ploemacher RE; Löwenberg B; Hagenbeek A; Martens AC
    Blood; 1997 Nov; 90(9):3735-42. PubMed ID: 9345060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
    Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
    Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential responses of CD34-positive acute myelogenous leukemic blasts to the costimulating effects of stem cell factor with GM-CSF and/or IL-3.
    Min YH; Lee ST; Lee BK; Chong SY; Lee S; Hahn JS; Ko YW
    Yonsei Med J; 1995 Mar; 36(1):26-36. PubMed ID: 7537932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia.
    Biethahn S; Alves F; Wilde S; Hiddemann W; Spiekermann K
    Exp Hematol; 1999 May; 27(5):885-94. PubMed ID: 10340405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
    Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
    Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3.
    Wunderlich M; Chou FS; Link KA; Mizukawa B; Perry RL; Carroll M; Mulloy JC
    Leukemia; 2010 Oct; 24(10):1785-8. PubMed ID: 20686503
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene immunotherapy in murine acute myeloid leukemia: granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines.
    Dunussi-Joannopoulos K; Dranoff G; Weinstein HJ; Ferrara JL; Bierer BE; Croop JM
    Blood; 1998 Jan; 91(1):222-30. PubMed ID: 9414288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative effects of GM-CSF signaling in a murine model of t(8;21)-induced leukemia.
    Matsuura S; Yan M; Lo MC; Ahn EY; Weng S; Dangoor D; Matin M; Higashi T; Feng GS; Zhang DE
    Blood; 2012 Mar; 119(13):3155-63. PubMed ID: 22223820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-9 stimulates the proliferation of human myeloid leukemic cells.
    Lemoli RM; Fortuna A; Tafuri A; Fogli M; Amabile M; Grande A; Ricciardi MR; Petrucci MT; Bonsi L; Bagnara G; Visani G; Martinelli G; Ferrari S; Tura S
    Blood; 1996 May; 87(9):3852-9. PubMed ID: 8611712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-3 and granulocyte-monocyte colony-stimulating factor receptors on human acute myelocytic leukemia cells and relationship to the proliferative response.
    Budel LM; Touw IP; Delwel R; Clark SC; Löwenberg B
    Blood; 1989 Aug; 74(2):565-71. PubMed ID: 2546627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable cytotoxicity of diphtheria toxin 388-granulocyte-macrophage colony-stimulating factor fusion protein for acute myelogenous leukemia stem cells.
    Feuring-Buske M; Frankel A; Gerhard B; Hogge D
    Exp Hematol; 2000 Dec; 28(12):1390-400. PubMed ID: 11146161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common binding structure for granulocyte macrophage colony-stimulating factor and interleukin-3 on human acute myeloid leukemia cells and monocytes.
    Budel LM; Elbaz O; Hoogerbrugge H; Delwel R; Mahmoud LA; Löwenberg B; Touw IP
    Blood; 1990 Apr; 75(7):1439-45. PubMed ID: 2156580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL.
    Li S; Gillessen S; Tomasson MH; Dranoff G; Gilliland DG; Van Etten RA
    Blood; 2001 Mar; 97(5):1442-50. PubMed ID: 11222392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor alpha modulates the messenger RNA expression of hematopoietic growth factor genes in fresh blast cells from patients with acute myeloblastic leukemia.
    Bergamaschi G; Cazzola M; Rosti V; Carlo-Stella C; Santini V; Ponchio L; Peverali FA; Della Valle G; Rossi Ferrini P; Ascari E
    Leukemia; 1991 Oct; 5(10):886-91. PubMed ID: 1961022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of MYC-repressed targets mediates the negative effects of GM-CSF on RUNX1-ETO leukemogenicity.
    Weng S; Matsuura S; Mowery CT; Stoner SA; Lam K; Ran D; Davis AG; Lo MC; Zhang DE
    Leukemia; 2017 Jan; 31(1):159-169. PubMed ID: 27389055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.